Did You Know? A yellow ribbon represents many things, including suicide prevention, support for American troops and for cancer warriors and survivors. It is a symbol for over 50 sub-types of malignant tumors that effect bones and soft tissue, otherwise known as Sarcomas. July is Sarcoma Awareness Month! Show your support for the fight against [...]
July is Sarcoma Awareness Month! 🎗 . Sarcomas effect more than 50,000 Americans with roughly 15,000 new cases each year, yet it is still largely considered a “forgotten” cancer due to a lack of research & drug development. . Sarcoma awareness month puts an emphasis on sarcoma education in communities around the world to ensure [...]
Thank you again to everyone who joined us for our 6th #BiteSizeResearch webinar on Friday. We hope you found the work of Professor Flanagan inspiring. If you missed it, you can now watch it via a YouTube link available on our main page: https://www.bcrt.org.uk/research/bitesizeresearch
Annamycin Demonstrates Efficacy for Lung Metastases in Preclinical Data Jun 25, 2020 Dylann Cohn-Emery Relevant Pages “In the case of sarcomas treated with the current standard of care, doxorubicin, tumors may be initially responsive in their primary location, but become unresponsive after metastasis to the lungs, which eventually becomes the most likely cause of patients’ [...]
Hi all, a pioneering new chondrosarcoma research project funded by BCRT has been announced today. Full details and link below We’re delighted to announce we have awarded Dr William Cross, from UCL Cancer Institute, ÂŁ70,000 to focus on chondrosarcoma research. Dr Cross’s pioneering one-year project will explore, for the first time, how mutations in chondrosarcoma [...]
In 9 days check out the webinar on Progress in Chondrosarcoma Research. Meet Adrienne Flanagan, Professor of Musculo- Skeletal Pathology at University College London’s Cancer Institute. As a highly accomplished medical researcher, Dr. Flanagan works closely with patient groups and focuses on identifying the genetic alterations involved in tumors to aid in the process of [...]
No Treatment Options Left: Fighting and Surviving Inoperable Cancer by Mike Snyder After facing the pain and turmoil of losing his left leg to a rare bone cancer called chondrosarcoma, Mike Snyder and his family thought their cancer battle was over. But their triumph would be short-lived. The cancer kept coming back even after the [...]
Meet Adrienne Flanagan, Professor of Musculo- Skeletal Pathology at University College London’s Cancer Institute. As a highly accomplished medical researcher, Dr. Flanagan works closely with patient groups and focuses on identifying the genetic alterations involved in tumors to aid in the process of diagnosing bone and soft tissues cancers like Chondrosarcoma. Dr. Flanagan will be [...]
Interesting article suggesting bone (and other) cancers contain a microenvironment conducive to distinctive bacterial populations https://medicalxpress.com/…/2020-05-cells-bacteria-cancer.h… Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers. The study, headed by researchers at the Weizmann Institute of Science, found bacteria living inside the [...]
Mike Snyder, a CS Warrior from Albuquerque, New Mexico and author of his book entitled: No Treatment Options Left: Fighting and Surviving Inoperable Cancer, contributed the first of many commentaries to provide straightforward information to CS patients. His article helps patients understand their diagnosis of Chondrosarcoma and gives advice on how to navigate through their [...]